Phibro Animal Health (PAHC) to Release Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is projected to post its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $0.40 per share and revenue of $292.26 million for the quarter. Phibro Animal Health has set its FY 2025 guidance at 1.340-1.480 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Wednesday, November 6th. The company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.12. The business had revenue of $260.40 million for the quarter, compared to the consensus estimate of $277.76 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. During the same quarter last year, the firm earned $0.14 EPS. On average, analysts expect Phibro Animal Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Phibro Animal Health Trading Down 0.6 %

Shares of NASDAQ:PAHC opened at $21.68 on Tuesday. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98. The firm has a fifty day moving average price of $21.98 and a 200 day moving average price of $21.56. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The stock has a market capitalization of $878.04 million, a PE ratio of 50.42, a P/E/G ratio of 0.56 and a beta of 0.52.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on PAHC shares. Barclays upped their target price on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. StockNews.com upgraded shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, January 29th. Finally, Morgan Stanley lifted their price objective on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.